(19)
(11)EP 2 420 232 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
02.05.2012 Bulletin 2012/18

(43)Date of publication A2:
22.02.2012 Bulletin 2012/08

(21)Application number: 11186078.9

(22)Date of filing:  04.10.2007
(51)Int. Cl.: 
A61K 31/41  (2006.01)
A61P 9/00  (2006.01)
A61K 31/4184  (2006.01)
A61P 13/12  (2006.01)
(84)Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
BA HR

(30)Priority: 06.10.2006 EP 06121905

(62)Application number of the earlier application in accordance with Art. 76 EPC:
07820908.7 / 2086535

(71)Applicant: Boehringer Ingelheim Vetmedica GmbH
55216 Ingelheim am Rhein (DE)

(72)Inventors:
  • Stark, Marcus
    55216 Ingelheim am Rhein (DE)
  • Sent, Ulrike
    55216 Ingelheim am Rhein (DE)
  • Lang, Ingo
    55216 Ingelheim am Rhein (DE)

(74)Representative: Hammann, Heinz et al
Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim am Rhein
55216 Ingelheim am Rhein (DE)

  


(54)Angiotensin II receptor antagonist for the prevention or treatment of cardiovascular diseases in cats


(57) The present invention relates to a method of prophylaxis or treatment of systemic diseases in cats, wherein the method comprising administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.